A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma

NCT06223646 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: KQ-2003 CAR T-cells

Sponsor

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.